Dr. Sarah Allison Wall, MD

Dr. Wall practices at OSU Internal Medicine in Columbus, Ohio.

Dr. Wall's NPI, 1174815708, was assigned on May 16, 2011. Dr. Wall holds Ohio license 35125837.

Dr. Wall's primary practice is OSU Internal Medicine, at 460 W 10th Ave, Columbus, OH 43210 in Franklin County. The practice phone is (614) 293-2229.

Dr. Wall's primary practice is OSU Internal Medicine in Columbus, Ohio. Dr. Wall is also affiliated with Ohio State University Hospital. The medical group on file is Ohio State University Physicians. Dmand AI also links Dr. Wall to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wall practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Wall's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Wall is board certified in hematology by the American Board of Internal Medicine. Dr. Wall is licensed in Ohio.

CMS data shows 580 Medicare services from Dr. Wall across 7 procedure codes in 2024, for 103 Medicare patients. Medicare paid $35,334 for them.

CMS counts 103 Medicare patients who saw Dr. Wall in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high blood pressure, and 68% have high cholesterol. Their average risk score is 3.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wall's median patient age at 68, with 41% women.

In 2024, Dr. Wall wrote 473 Medicare Part D claims for 64 patients. 37% of them were for generic drugs. CMS names the drug for 323 of them, across 8 drugs with 11 or more claims each, at $5,770,015 in total drug cost. In 2023, CMS named 252 claims across 8 drugs.

Dr. Wall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wall as offering telehealth.

Dmand AI links 46 papers to Dr. Wall, published from 2015 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Hematopoietic Stem Cell Transplantation, Geriatric Assessment and Hematologic Neoplasms. Dr. Wall has published most often in Transplant Cell Ther. Dr. Wall's most frequent co-authors are Sumithira Vasu, MD, Alice Scott Mims, MD and Ashley Elizabeth Rosko, MD.

Dmand AI links Dr. Wall to 3 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Mastocytosis, Systemic, Myelodysplastic Syndromes and Primary Myelofibrosis.

CMS Open Payments shows 31 general payments to Dr. Wall from 12 drug and device companies from 2022 to 2025. Speaker and faculty fees make up the largest share, 42% of the total. Sobi, Inc paid the most, $14,243.